| SAI | Self-Analysis Inventory; Sexual Arousability Inventory; Social Adequacy Index; suppressor of anchora... |
|---|---|
| SCA | self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| SIRS | soluble immune response suppressor; Structured Interview of Reported Symptoms; systemic inflammatory... |
| SSCA | spontaneous suppressor cell activity |
| T-lymphocytes, suppressor-inducer | Subpopulation of CD4+ lymphocytes which induce CD8+ suppressor T-cells (T-lymphocytes, suppressor-effector) to suppress antibody production by B-cells. They also stimulate other cellular immune responses. (12 Dec 1998) |
|---|---|
| T suppressor cell | <haematology, immunology> Set of T lymphocytes (usually CD8) specifically involved in suppressing B-cell differentiation into antibody secreting cells. There may also be T suppresors of T-cell functions. (18 Nov 1997) |
| t-suppressor cell | A type of immune cells, also called t8 cells, these cells close down the immune response after it has destroyed invading organisms. T8 cells are sensitive to high concentrations of circulating lymphokine hormones and release their own lymphokines after an immune response has achieved its goal, signalling all other participants to cease their attack. Some memory B-cells remain to ward off a repeat attack by the invading organism. (12 Dec 1998) |
| acinar cell tumour | A solid and cystic tumour of the pancreas, occurring in young women; tumour cells contain zymogen granules. (05 Mar 2000) |
| acute splenic tumour | Acute splenitis, enlargement, and softening of the spleen, usually due to bacteraemia or severe bacterial toxaemia. (05 Mar 2000) |
| adenoid tumour | Adenoma, or neoplasm with glandlike spaces. (05 Mar 2000) |
| adenomatoid odontogenic tumour | A benign epithelial odontogenic tumour appearing radiographically as a well-circumscribed radiolucent-radiopaque lesion usually surrounding the crown of an impacted tooth in an adolescent or young adult; characterised histologically by columnar cells organised in a duct-like configuration interspersed with spindle-shaped cells and amyloid-like deposition that gradually undergoes dystrophic calcification. Synonym: adenoameloblastoma, ameloblastic adenomatoid tumour. (05 Mar 2000) |
| adenomatoid tumour | A small, circumscribed, benign tumour of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (12 Dec 1998) |
| adipose tumour | <oncology, tumour> Clumps of fat cells. Literally, fat cancer. These are benign tumours that can form in the breast. (16 Dec 1997) |
| adrenal gland tumour | <oncology> A benign tumour or adenoma, that usually results in the excess production of adrenal gland hormones. (27 Sep 1997) |
| adrenal rest tumour | A rare, usually benign, ovarian tumour thought to be derived from embryonic rest cells of the adrenals. This tumour causes various degrees of masculinization. (12 Dec 1998) |
| ameloblastic adenomatoid tumour | A benign epithelial odontogenic tumour appearing radiographically as a well-circumscribed radiolucent-radiopaque lesion usually surrounding the crown of an impacted tooth in an adolescent or young adult; characterised histologically by columnar cells organised in a duct-like configuration interspersed with spindle-shaped cells and amyloid-like deposition that gradually undergoes dystrophic calcification. Synonym: adenoameloblastoma, ameloblastic adenomatoid tumour. (05 Mar 2000) |
| amyloid tumour | A localised form of amyloidosis in which amyloid occurs as masses or nodules beneath the skin or mucous membranes, e.g., in the larynx. Synonym: amyloid tumour, focal amyloidosis. (05 Mar 2000) |
| angiomatoid tumour | A small, circumscribed, benign tumour of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (12 Dec 1998) |
| antigens, tumour-associated, carbohydrate | Carbohydrate antigens expressed by malignant tissue. They are useful as tumour markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. (12 Dec 1998) |